154 related articles for article (PubMed ID: 31417495)
21. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
Johnson SJ; Hardy SA; Roberts C; Bourn D; Mallick U; Perros P
Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615
[TBL] [Abstract][Full Text] [Related]
22. Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.
Vuong HG; Altibi AM; Duong UN; Ngo HT; Pham TQ; Tran HM; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R; Kondo T
Tumour Biol; 2017 Oct; 39(10):1010428317713913. PubMed ID: 29037127
[TBL] [Abstract][Full Text] [Related]
23. Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.
Song YS; Lim JA; Choi H; Won JK; Moon JH; Cho SW; Lee KE; Park YJ; Yi KH; Park DJ; Seo JS
Cancer; 2016 May; 122(9):1370-9. PubMed ID: 26969876
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules.
Sahin M; Gursoy A; Tutuncu NB; Guvener DN
Clin Endocrinol (Oxf); 2006 Oct; 65(4):514-8. PubMed ID: 16984245
[TBL] [Abstract][Full Text] [Related]
25. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
26. Pre-operative role of BRAF in the guidance of the surgical approach and prognosis of differentiated thyroid carcinoma.
Danilovic DL; Lima EU; Domingues RB; Brandão LG; Hoff AO; Marui S
Eur J Endocrinol; 2014 Apr; 170(4):619-25. PubMed ID: 24468978
[TBL] [Abstract][Full Text] [Related]
27. Patients with Indeterminate Thyroid Nodules at Cytology and Cancer at Histology Have a More Favorable Outcome Compared with Patients with Suspicious or Malignant Cytology.
Rago T; Scutari M; Loiacono V; Tonacchera M; Scuotri G; Romani R; Proietti A; Piaggi P; Elisei R; Basolo F; Latrofa F; Vitti P
Thyroid; 2018 Oct; 28(10):1318-1324. PubMed ID: 30132418
[TBL] [Abstract][Full Text] [Related]
28. Papillary and follicular thyroid carcinoma metastatic to the skin: a case report and review of the literature.
Koller EA; Tourtelot JB; Pak HS; Cobb MW; Moad JC; Flynn EA
Thyroid; 1998 Nov; 8(11):1045-50. PubMed ID: 9848721
[TBL] [Abstract][Full Text] [Related]
29. Red lesions of the iris, choroid, and skin secondary to metastatic carcinoma of the thyroid: a review.
Arat YO; Boniuk M
Surv Ophthalmol; 2007; 52(5):523-8. PubMed ID: 17719373
[TBL] [Abstract][Full Text] [Related]
30. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
[TBL] [Abstract][Full Text] [Related]
32. An intra-thoracic follicular carcinoma of thyroid: An uncommon presentation.
Kant S; Srivastava A; Kumar R; Verma AK; Mishra AK; Husain N
Lung India; 2017; 34(2):193-196. PubMed ID: 28360474
[TBL] [Abstract][Full Text] [Related]
33. Metastatic thyroid follicular carcinoma presenting as pathological left clavicle fracture: An unusual skeletal metastasis at the time of diagnosis.
Nilojan JS; Raviraj S; Madhuwantha UVP; Mathuvanthi T; Priyatharsan K
Int J Surg Case Rep; 2024 Jan; 114():109131. PubMed ID: 38128290
[TBL] [Abstract][Full Text] [Related]
34. Young Investigator Challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
Jiang XS; Harrison GP; Datto MB
Cancer Cytopathol; 2016 Dec; 124(12):893-900. PubMed ID: 27893191
[TBL] [Abstract][Full Text] [Related]
35. Clinical, Sonographic, and Pathological Characteristics of RAS-Positive Versus BRAF-Positive Thyroid Carcinoma.
Kakarmath S; Heller HT; Alexander CA; Cibas ES; Krane JF; Barletta JA; Lindeman NI; Frates MC; Benson CB; Gawande AA; Cho NL; Nehs M; Moore FD; Marqusee E; Kim MI; Larsen PR; Kwong N; Angell TE; Alexander EK
J Clin Endocrinol Metab; 2016 Dec; 101(12):4938-4944. PubMed ID: 27689252
[TBL] [Abstract][Full Text] [Related]
36. TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
Gandolfi G; Ragazzi M; Frasoldati A; Piana S; Ciarrocchi A; Sancisi V
Eur J Endocrinol; 2015 Apr; 172(4):403-13. PubMed ID: 25583906
[TBL] [Abstract][Full Text] [Related]
37. Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF (V600E) Harboring Pediatric Papillary Thyroid Carcinomas.
Onder S; Ozturk Sari S; Yegen G; Sormaz IC; Yilmaz I; Poyrazoglu S; Sanlı Y; Giles Senyurek Y; Kapran Y; Mete O
Endocr Pathol; 2016 Jun; 27(2):153-61. PubMed ID: 26951110
[TBL] [Abstract][Full Text] [Related]
38. TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma.
Oh EJ; Lee S; Bae JS; Kim Y; Jeon S; Jung CK
Endocr Pathol; 2017 Mar; 28(1):49-53. PubMed ID: 27688081
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.
Schulten HJ; Salama S; Al-Ahmadi A; Al-Mansouri Z; Mirza Z; Al-Ghamdi K; Al-Hamour OA; Huwait E; Gari M; Al-Qahtani MH; Al-Maghrabi J
Anticancer Res; 2013 Nov; 33(11):4779-84. PubMed ID: 24222113
[TBL] [Abstract][Full Text] [Related]
40. BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.
Ohori NP; Singhal R; Nikiforova MN; Yip L; Schoedel KE; Coyne C; McCoy KL; LeBeau SO; Hodak SP; Carty SE; Nikiforov YE
Cancer Cytopathol; 2013 Apr; 121(4):197-205. PubMed ID: 22887810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
